Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Thorax 2008;63:295
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wedzicha, W.
PubMed
Right arrow Articles by Wedzicha, W.
Topic Collections
Right arrowRelated Articles

Airwaves

Wisia Wedzicha, Editor-in-Chief

The first 150 words of the full text of this article appear below.


*    β BLOCKERS REDUCE MORTALITY IN COPD
 
It is well known that β blockers reduce mortality in patients with cardiovascular disease. COPD is often complicated by cardiovascular disease and patients are often not treated with β blockers due to concern over possible worsening of airways obstruction, even though cardioselective β blockers have little deleterious effect on airway function. In this issue, Dransfield and colleagues report a study of patients with COPD hospitalised with an exacerbation. The authors show, after correcting for relevant confounders, that COPD patients treated with β blockers have a lower in-patient mortality, than those patients not treated with β blockers. In the accompanying editorial Au summarises some of the reasons for the reduction in mortality observed in this study and concludes that β blockers appear to be safe in COPD. As cardiovascular disease is so common in COPD, Au points out that the effectiveness of β blockers on mortality deserves further study.

See pages . . . [Full text of this article]


Related Articles

Hereditary disorders of surfactant homeostasis cause acute and chronic lung disease in infancy
Jeffrey A Whitsett
Thorax 2008 63: 295-296. [Extract] [Full Text] [PDF]

Use of β blockers in patients with COPD
David H Au
Thorax 2008 63: 296-298. [Extract] [Full Text] [PDF]

Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
M T Dransfield, S M Rowe, J E Johnson, W C Bailey, and L B Gerald
Thorax 2008 63: 301-305. [Abstract] [Full Text] [PDF]

Telomerase activity in transthoracic fine needle biopsy aspirates as a marker of peripheral lung cancer
T Targowski, K Jahnz-Rózyk, T Szkoda, S From, N Qandil, and T Plusa
Thorax 2008 63: 342-344. [Abstract] [Full Text] [PDF]

Clinical, radiological and pathological features of ABCA3 mutations in children
M L Doan, R P Guillerman, M K Dishop, L M Nogee, C Langston, G B Mallory, M M Sockrider, and L L Fan
Thorax 2008 63: 366-373. [Abstract] [Full Text] [PDF]

Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia
J L Davis, D A Welsh, C B Beard, J L Jones, G G Lawrence, M R Fox, K Crothers, A Morris, D Charbonnet, A Swartzman, and L Huang
Thorax 2008 63: 329-334. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society